AnorMED Inc. (AMEX: AOM) announced that its Board of Directors has unanimously rejected an unsolicited approach from Genzyme Corporation (Nasdaq ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE